Amoebic gill disease (AGD) is considered to be the most significant health problem for farmed Atlantic salmon in Tasmania, costing the industry an estimated $15-20 million pa. It is caused by the presence of Neoparamoeba spp. on the gills and if untreated can lead to death. Although some control of...
The salmon industry is one of Australia’s largest aquaculture industries and produced approximately 16,000 tonnes of farmed Atlantic salmon, Salmo salar, in 2001/02 at an estimated farm gate value of $170 million. The industry is a major regional and youth employer and is based in Tasmania...
This project has increased our knowledge of Amoebic Gill Disease, in particular about the pathogen and the dynamics of infection. We have described a new species of neoparamoeba, Neoparamoeba perurans, and showed that it has been consistently associated with AGD worldwide. Stocking...
This project significantly increased our knowledge and understanding of Amoebic Gill Disease (AGD). We developed tools and techniques applicable to further research on AGD and other fish diseases. This project contributed to education and training in the area of fish health. Five PhD...
Before this project our knowledge of immune response in Amoebic Gill Disease (AGD) was fundamentally limited and more information was required to assess the potential for immunomodulators in the management of AGD.
We confirmed that injection of bacterial DNA motif (CpG oligonucleotides) six...
Amoebic Gill Disease (AGD) is the main health problem affecting salmon industry in Southern Tasmania. To improve management of fish with AGD on the farms, the industry needs better understanding of AGD epidemiology. This will provide a basis on which to develop strategies for new...
Before this project our knowledge of the effects of husbandry on Amoebic Gill Disease (AGD) was limited. This project allowed on-farm assessment of effects of husbandry procedures and stock characteristics on AGD severity. Furthermore, we investigated the potential to re-use fresh water for...